These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 38399240)

  • 1. Biomaterial-Based Responsive Nanomedicines for Targeting Solid Tumor Microenvironments.
    Avgoustakis K; Angelopoulou A
    Pharmaceutics; 2024 Jan; 16(2):. PubMed ID: 38399240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticancer nanomedicines harnessing tumor microenvironmental components.
    Li Y; Chen Z; Gu L; Duan Z; Pan D; Xu Z; Gong Q; Li Y; Zhu H; Luo K
    Expert Opin Drug Deliv; 2022 Apr; 19(4):337-354. PubMed ID: 35244503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted nanomedicines remodeling immunosuppressive tumor microenvironment for enhanced cancer immunotherapy.
    Xu Y; Xiong J; Sun X; Gao H
    Acta Pharm Sin B; 2022 Dec; 12(12):4327-4347. PubMed ID: 36561994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-Targeted Nanomedicine for Immunotherapy.
    Cabral H; Kinoh H; Kataoka K
    Acc Chem Res; 2020 Dec; 53(12):2765-2776. PubMed ID: 33161717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combining Nanomedicine and Immunotherapy.
    Shi Y; Lammers T
    Acc Chem Res; 2019 Jun; 52(6):1543-1554. PubMed ID: 31120725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting Tumor Microenvironment for Cancer Therapy.
    Roma-Rodrigues C; Mendes R; Baptista PV; Fernandes AR
    Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30781344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of stimuli responsive polymeric nanomedicines modulating tumor microenvironment for improved cancer therapy.
    Su Y; Jin G; Zhou H; Yang Z; Wang L; Mei Z; Jin Q; Lv S; Chen X
    Med Rev (2021); 2023 Feb; 3(1):4-30. PubMed ID: 37724108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined cancer therapeutics-Tackling the complexity of the tumor microenvironment.
    Roma-Rodrigues C; Raposo LR; Valente R; Fernandes AR; Baptista PV
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Sep; 13(5):e1704. PubMed ID: 33565269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor Abnormality-Oriented Nanomedicine Design.
    Zhou Q; Xiang J; Qiu N; Wang Y; Piao Y; Shao S; Tang J; Zhou Z; Shen Y
    Chem Rev; 2023 Sep; 123(18):10920-10989. PubMed ID: 37713432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three Strategies in Engineering Nanomedicines for Tumor Microenvironment-Enabled Phototherapy.
    He S; Jia X; Feng S; Hu J
    Small; 2023 Sep; 19(37):e2300078. PubMed ID: 37226364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Responsive Role of Nanomedicine in the Tumor Microenvironment and Cancer Drug Resistance.
    Sa P; Sahoo SK; Dilnawaz F
    Curr Med Chem; 2023; 30(29):3335-3355. PubMed ID: 36154585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Remodeling tumor microenvironment with nanomedicines.
    Martin JD; Miyazaki T; Cabral H
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Nov; 13(6):e1730. PubMed ID: 34124849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor microenvironment reprogramming by nanomedicine to enhance the effect of tumor immunotherapy.
    Huang Y; Fan H; Ti H
    Asian J Pharm Sci; 2024 Apr; 19(2):100902. PubMed ID: 38595331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polysaccharide-Based Stimulus-Responsive Nanomedicines for Combination Cancer Immunotherapy.
    Li Q; Liu X; Yan C; Zhao B; Zhao Y; Yang L; Shi M; Yu H; Li X; Luo K
    Small; 2023 Jun; 19(23):e2206211. PubMed ID: 36890780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Boosting Nanomedicine Efficacy with Hyperbaric Oxygen Therapy.
    Wang X; Li S; Liu X; Wu X; Ye N; Yang X; Li Z
    Adv Exp Med Biol; 2021; 1295():77-95. PubMed ID: 33543456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current advances in nanoformulations of therapeutic agents targeting tumor microenvironment to overcome drug resistance.
    Fakhri S; Moradi SZ; Faraji F; Farhadi T; Hesami O; Iranpanah A; Webber K; Bishayee A
    Cancer Metastasis Rev; 2023 Sep; 42(3):959-1020. PubMed ID: 37505336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Responsive and activable nanomedicines for remodeling the tumor microenvironment.
    Zhang Y; Han X; Nie G
    Nat Protoc; 2021 Jan; 16(1):405-430. PubMed ID: 33311713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor microenvironment-regulating nanomedicine design to fight multi-drug resistant tumors.
    Xu Q; Lan X; Lin H; Xi Q; Wang M; Quan X; Yao G; Yu Z; Wang Y; Yu M
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023 Jan; 15(1):e1842. PubMed ID: 35989568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting tumor microenvironment and metastasis in children with solid tumors.
    Wessel KM; Kaplan RN
    Curr Opin Pediatr; 2022 Feb; 34(1):53-60. PubMed ID: 34812775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in Nanoplatforms for Immunotherapy Applications Targeting the Tumor Microenvironment.
    Zhang N; Zhou J; Li S; Cai W; Ru B; Hu J; Liu W; Liu X; Tong X; Zheng X
    Mol Pharm; 2024 Feb; 21(2):410-426. PubMed ID: 38170627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.